Home › Researcher directory › Steffen Borrmann
Steffen Borrmann
Affiliation : Kenya Medical Research Institute · KEMRI-Wellcome Trust Research Programme
- 30Publications (affiliation in Kenya)
Research profile
Steffen Borrmann has 30 indexed publications (2005–2018). Their work appears mainly in “PLoS ONE”, “Antimicrobial Agents and Chemotherapy” and “PLoS Medicine”. Their most cited article, “Spread of Artemisinin Resistance in Plasmodium falciparum Malaria” (2014), has been cited 2205 times. 2 of these publications date from the last three years of activity. Their work is co-authored with at least 12 researchers, including institutions in United Kingdom, United States, Germany, Gabon.
Is this you? Get your research seen
Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.
Create my free profile Add my publicationsPublications (30)
- Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis
- Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis
- Novel approaches to whole sporozoite vaccination against malaria
- Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
- A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains
- A micro-epidemiological analysis of febrile malaria in Coastal Kenya showing hotspots within hotspots
- Dihydroartemisinin-Piperaquine vs. Artemether-Lumefantrine for First-Line Treatment of Uncomplicated Malaria in African Children: A Cost-Effectiveness Analysis
- Genome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in Kenya
- Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives
- PlasmoView: A Web-based Resource to Visualise Global Plasmodium falciparum Genomic Variation
- Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing
- Declining Responsiveness of Plasmodium falciparum Infections to Artemisinin-Based Combination Treatments on the Kenyan Coast
- Population Genetic Analysis of Plasmodium falciparum Parasites Using a Customized Illumina GoldenGate Genotyping Assay
- Induction of Antimalaria Immunity by Pyrimethamine Prophylaxis during Exposure to Sporozoites Is Curtailed by Parasite Resistance
- Targeting Plasmodium liver stages: better late than never
- Pharmacokinetic and Pharmacodynamic Characteristics of a New Pediatric Formulation of Artemether-Lumefantrine in African Children with Uncomplicated Plasmodium falciparum Malaria
- Natural Immunization Against Malaria: Causal Prophylaxis with Antibiotics
- The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem®) for acute uncomplicatedPlasmodium falciparummalaria
- Defining Clinical Malaria: The Specificity and Incidence of Endpoints from Active and Passive Surveillance of Children in Rural Kenya
- In Vitro Activities of Quinine and Other Antimalarials and pfnhe Polymorphisms in Plasmodium Isolates from Kenya
- Chloroquine resistance before and after its withdrawal in Kenya
- In Vitro Activities of Piperaquine, Lumefantrine, and Dihydroartemisinin in Kenyan Plasmodium falciparum Isolates and Polymorphisms in p fcrt and p fmdr1
- Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial
- Chlorproguanil−Dapsone−Artesunate versus Artemether−Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria
- In Vitro Activity of Antifolate and Polymorphism in Dihydrofolate Reductase ofPlasmodium falciparumIsolates from the Kenyan Coast: Emergence of Parasites with Ile-164-Leu Mutation
- In Vivo and In Vitro Efficacy of Amodiaquine againstPlasmodium falciparumin an Area of Continued Use of 4‐Aminoquinolines in East Africa
- Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial
- Effects of Plasmodium falciparum Parasite Population Size and Patient Age on Early and Late Parasitological Outcomes of Antimalarial Treatment in Children
- Delayed parasite elimination in human infections treated with clindamycin parallels ‘delayed death’ of Plasmodium falciparum in vitro
- SHORT REPORT: PILOTING PAPERLESS DATA ENTRY FOR CLINICAL RESEARCH IN AFRICA
Publication venues
- PLoS ONE × 6
- Antimicrobial Agents and Chemotherapy × 6
- PLoS Medicine × 2
- Malaria Journal × 2
- The Journal of Infectious Diseases × 2
- Vaccine × 1
Publications per year
- 20181
- 20171
- 20151
- 20144
- 20133
- 20121
- 20115
- 20104
- 20096
- 20082
Collaborations
Partner institutions : University of Oxford · Wellcome Trust · John Radcliffe Hospital · Boston Children's Hospital · Albert Schweitzer Hospital
Co-authors’ countries : United Kingdom · United States · Germany · Gabon
Co-authors
- Leah Mwai
- Alexis M. Nzila
- Kevin Marsh
- Steven M. Kiara
- Philip Galula Sasi
- Mahfudh M. Bashraheil
- Judy Peshu
- Elizabeth A Juma
- Brett S Lowe
- Steven Muriithi
- Abdirahman I. Abdi
- John Okombo
Bibliographic data from OpenAlex (open database).
Why choose DzCademia?
Profiles, articles and conference contributions: give your research a structured public presence. Integrated metadata help search engines and AI assistants identify your work and understand its references.
Comment with Google
Sign in with Google to comment directly on this page.